Shiravand, Yavar; Walter, Ulrich; Jurk, Kerstin
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases-Just the BeginningHAMOSTASEOLOGIE. Bd. 41. H. 03. 2021 S. 206-216
Patt, Marianne; Bengel, Frank; Essler, Markus et al.
Fireside chat " 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020-DigitalNUKLEARMEDIZIN-NUCLEAR MEDICINE. Bd. 60. H. 04. 2021 S. 262-263
Waldeck, Stephan; Chapot, Rene; von Falck, Christian et al.
First Experience in the Control of the Venous Side of the Brain AVMJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 24. 2021
Deutschbein, Timo; Jaursch-Hancke, Cornelia; Knappe, Ulrich J. et al.
First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary TumorsEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 129. H. 3. 2021 S. 250-264
Aboulmaouahib, Brahim; Kastenmueller, Gabi; Suhre, Karsten et al.
First mitochondrial genome-wide association study with metabolomicsHUMAN MOLECULAR GENETICS. 2021
Diel, Heidi; Ding, Can; Grehn, Franz et al.
First observation of secondary childhood glaucoma in Coffin-Siris syndrome: a case report and literature reviewBMC OPHTHALMOLOGY. Bd. 21. H. 1. 2021
Diel, Heidi; Ding, Can; Grehn, Franz et al.
First observation of secondary childhood glaucoma in Coffin-Siris syndrome: a case report and literature review (vol 21, 28, 2021)BMC OPHTHALMOLOGY. Bd. 21. H. 1. 2021 S. 0-0
Moehler, Markus H.; Shitara, Kohei; Garrido, Marcelo et al.
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Moehler, M.; Shitara, K.; Garrido, M. et al.
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): expanded efficacy and safety data from CheckMate 649ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 79-80
Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus et al.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialLANCET. Bd. 398. H. 10294. 2021 S. 27-40